Thrombomodulin (TM), which is predominantly expressed on the endothelium, plays an important role in maintaining vascular homeostasis by regulating the coagulation system …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing …
CC Dvorak, C Higham, KA Shimano - Frontiers in Pediatrics, 2019 - frontiersin.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is an endothelial damage syndrome that is increasingly identified as a complication of both autologous and allogeneic …
GC Hildebrandt, N Chao - British Journal of Haematology, 2020 - Wiley Online Library
Use of haematopoietic cell transplantation (HCT) in the treatment of haematologic and neoplastic diseases may lead to life‐threatening complications that cause substantial …
S Meri, D Bunjes, R Cofiell, S Jodele - Advances in Therapy, 2022 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT- TMA) is a common complication occurring post-HSCT and is associated with substantial …
T Ikezoe - International journal of hematology, 2021 - Springer
Haematological malignancies, including acute leukaemia and non-Hodgkin lymphoma, are one of the underlying diseases that frequently cause disseminated intravascular coagulation …
E Gavriilaki, VT Ho, W Schwaeble, T Dudler… - … hematology & oncology, 2021 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT- TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after …
S Kraft, N Bollinger, B Bodenmann, D Heim… - Bone marrow …, 2019 - nature.com
Transplant-associated thrombotic microangiopathy (TA-TMA) remains a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). We hypothesized that TA …